Search
for
Sort by
Research 61–90 of 1000+
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- A systematic review of dermatologic manifestations among adult patients with COVID‐19 diagnosis
- Pregnancy and Skin
- Neutralization of IL-8 Prevents the Induction of Dermatologic Adverse Events Associated with the Inhibition of Epidermal Growth Factor Receptor
- Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Scalp Pustule as a Manifestation of Erlotinib-Induced Skin Toxicity: Report of Two Cases and Literature Review
- Keratosis Pilaris-like Eruption during Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors: Literature Review and Report of a Case Related to Imatinib
- A linear and reticulate crusted keratotic papulopustular eruption: a rare presentation of PRIDE (Papulopustules and/or paronychia, Regulatory abnormalities of hair growth, Itching, and Dryness due to Epidermal growth factor receptor inhibitors) complex
- Laser-Assisted Drug Delivery: A Systematic Review of Safety and Adverse Events
- Dermatolojik Problemler ve COVID-19
- Medications
- Nanostructured Lipid Carrier for Topical Application of N-Acetyl Glucosamine
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Reporting on Adverse Clinical Events
- Madarosis
- Ingestion of a dietary supplement resulting in selenium toxicity
- Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management
- Adverse Reactions to Biologic Medications Used in Allergy and Immunology Diseases
- Management of Skin Toxicities in Cancer Treatment: An Australian/New Zealand Perspective
- Cutaneous manifestations and considerations in COVID ‐19 pandemic: A systematic review
- Unveiling the Nuances of Adult Female Acne: A Comprehensive Exploration of Epidemiology, Treatment Modalities, Dermocosmetics, and the Menopausal Influence
- EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
- Taiwanese Dermatological Association consensus for the prevention and management of epidermal growth factor receptor tyrosine kinase inhibitor-related skin toxicities
- Dermatologic Effects of Selumetinib in Pediatric Patients with Neurofibromatosis Type 1: Clinical Challenges and Therapeutic Management
- Management of Dermatologic Toxicities
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- Follicular dystrophy of immunosuppression
- Skin manifestations associated with systemic diseases – Part I
- Folliculitis decalvans: a case report of satisfactory recovery after implementing isotretinoin therapy